Tacrolimus-resistant SARS-CoV-2-specific T cell products to prevent and treat severe COVID-19 in immunosuppressed patients - Lena Peter; Désirée Jacqueline Wendering; Stephan Schlickeiser; Henrike Hoffmann; Rebecca Noster; Dimitrios Laurin Wagner; Ghazaleh Zarrinrad; Sandra Münch; Samira Picht; Sarah Schulenberg; Hanieh Moradian; Mir-Farzin Mashreghi; et al. (Molecular Therapy: Methods & Clinical Development, 2022)